Resources

The latest in from biologics discovery and development through to production and supply chain management.

Biosimilars & Biobetters

FDA's AI Model Enhances Safety of Biosimilar Therapeutic Proteins

Thanks to the FDA's new AI-powered imaging tool, the safety profile of newly developed biosimilar therapeutic protiens may improve.
Biosimilars & Biobetters

Biocon’s Biosimilar Difficulties: Successive FDA Rejections Don’t Inspire Hope

Biocon suffer another FDA rejection due to data and manufacturing concerns, this time for their bevacizumab biosimilar.
Biosimilars & Biobetters

Retinal Disease Drug Receives Approval from European Commission

Ranivisio is a biosimilar of Lucentis which treats serious retinal diseases.

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things biologics